Emerging molecular therapies targeting myocardial infarction-related arrhythmias

Area of Science:

• Cardiovascular Medicine
• Regenerative Medicine
• Molecular Cardiology

Background:

• Cardiac disease is the leading cause of death globally.
• Ventricular arrhythmias from myocardial ischemia/infarction significantly contribute to cardiovascular mortality.
• Current treatments (drugs, devices, ablation) have limitations including ineffectiveness, toxicity, and tissue damage.

Purpose of the Study:

• To explore gene and cell therapies as novel approaches for treating ischemia- and infarction-related arrhythmias.
• To address the limitations of existing therapeutic strategies for ventricular arrhythmias.
• To investigate potential regenerative and targeted interventions for cardiovascular conditions.

Main Methods:

• Review and analysis of current research in gene and cell therapy for cardiac arrhythmias.
• Exploration of the mechanisms underlying the potential efficacy of these novel therapies.
• Assessment of the potential for targeted, non-destructive, and regenerative approaches.

Main Results:

• Gene and cell therapies are emerging as potential treatments for arrhythmias.
• These therapies offer a targeted approach, addressing specific triggers or substrates.
• They hold the potential for non-destructive and regenerative effects on cardiac tissue.

Conclusions:

• Gene and cell therapies represent a promising frontier in managing cardiac arrhythmias.
• These approaches may overcome the limitations of conventional treatments.
• Further development is crucial to realize their full potential in preventing and treating cardiovascular mortality.